Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 29 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Pagourelias, Efstathios D  [Clear All Filters]
Journal Article
Rouska, E., Charokopos N., Pagourelias E. D., Artemiou P., Ziakas A., & Papadopoulos N. (2011).  Aortic root replacement in case of isolated aortitis and previous coronary artery bypass.. Hellenic J Cardiol. 52(5), 444-7.
Pagourelias, E. D., Efthimiadis G. K., Kouidi E., Fragakis N., Athyros V. G., & Geleris P. (2011).  Athlete's heart or hypertrophic cardiomyopathy: the dilemma is still there.. Am J Cardiol. 108(12), 1841-2.
Charokopos, N. A., Rouska E., Pliakos C., Pagourelias E. D., Artemiou P., Foroulis C., et al. (2009).  Atypical atrial myxomas in two asymptomatic patients: a case report.. Cardiovasc Ultrasound. 7, 45.
Pagourelias, E. D., Zorou P. G., Tsaligopoulos M., Athyros V. G., Karagiannis A., & Efthimiadis G. K. (2011).  Carbon dioxide balneotherapy and cardiovascular disease.. Int J Biometeorol. 55(5), 657-63.
Pagourelias, E. D., Koumaras C., Kakafika A. I., Tziomalos K., Zorou P. G., Athyros V. G., et al. (2009).  Cardiorenal anemia syndrome: do erythropoietin and iron therapy have a place in the treatment of heart failure?. Angiology. 60(1), 74-81.
Efthimiadis, G. K., Giannakoulas G., Parcharidou D. G., Pagourelias E. D., Kouidi E. J., Spanos G., et al. (2011).  Chronotropic incompetence and its relation to exercise intolerance in hypertrophic cardiomyopathy.. Int J Cardiol. 153(2), 179-84.
Efthimiadis, G. K., Pagourelias E. D., Parcharidou D., Gossios T., Kamperidis V., Theofilogiannakos E. K., et al. (2013).  Clinical characteristics and natural history of hypertrophic cardiomyopathy with midventricular obstruction.. Circ J. 77(9), 2366-74.
Efthimiadis, G. K., & Pagourelias E. D. (2009).  Delayed hyperenhancement magnetic resonance imaging for sudden cardiac death risk stratification in hypertrophic cardiomyopathy.. J Am Coll Cardiol. 55(1), 77.
Athyros, V. G., Tziomalos K., Mikhailidis D. P., Pagourelias E. D., Kakafika A. I., Skaperdas A., et al. (2007).  Do we need a statin-nicotinic acid-aspirin mini-polypill to treat combined hyperlipidaemia?. Expert Opin Pharmacother. 8(14), 2267-77.
Karagiannis, A., Tziomalos K., Pagourelias E. D., Gossios T. D., & Athyros V. G. (2010).  Effect of antihypertensive drug-associated diabetes on cardiovascular risk.. Hellenic J Cardiol. 51(3), 195-9.
Efthimiadis, G. K., Pagourelias E. D., Hadjimiltiades S., Meditskou S., Karvounis H., & McKenna W. J. (2014).  Feasibility and Significance of Preclinical Diagnosis in Hypertrophic Cardiomyopathy.. Cardiol Rev.
Efthimiadis, G. K., Pagourelias E. D., Hadjimiltiades S., Meditskou S., Karvounis H., & McKenna W. J. (2015).  Feasibility and significance of preclinical diagnosis in hypertrophic cardiomyopathy.. Cardiol Rev. 23(6), 297-302.
Efthimiadis, G. K., Pliakos C., Pagourelias E. D., Parcharidou D. G., Spanos G., Paraskevaidis S., et al. (2009).  Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm formation in a single family: case report.. Cardiovasc Ultrasound. 7, 26.
Efthimiadis, G. K., Pliakos C., Pagourelias E. D., Parcharidou D. G., Giannakoulas G., Kamperidis V., et al. (2009).  Identification of high risk patients with hypertrophic cardiomyopathy in a northern Greek population.. Cardiovasc Ultrasound. 7, 37.
Athyros, V. G., Tziomalos K., Katsiki N., Gossios T. D., Giouleme O., Anagnostis P., et al. (2013).  The impact of smoking on cardiovascular outcomes and comorbidities in statin-treated patients with coronary artery disease: a post hoc analysis of the GREACE study.. Curr Vasc Pharmacol. 11(5), 779-84.
Vassilikos, V. P., Pagourelias E. D., Katsos K., Zaggelidou E., Raikos N., Tzikas S., et al. (2020).  Impact of social containment measures on cardiovascular admissions and sudden cardiac death rates during Coronavirus Disease (COVID-19) outbreak in Greece.. Hellenic J Cardiol.
Pagourelias, E. D., Sotiriou P., Papadopoulos C. E., Cholongitas E., Giouleme O., & Vassilikos V. (2016).  Left Ventricular Myocardial Mechanics in Cirrhosis: A Speckle Tracking Echocardiographic Study.. Echocardiography. 33(2), 223-32.
Efthimiadis, G. K., Parcharidou D. G., Giannakoulas G., Pagourelias E. D., Charalampidis P., Savvopoulos G., et al. (2009).  Left ventricular outflow tract obstruction as a risk factor for sudden cardiac death in hypertrophic cardiomyopathy.. Am J Cardiol. 104(5), 695-9.
Efthimiadis, G. K., Parcharidou D., Pagourelias E. D., Meditskou S., Spanos G., Hadjimiltiades S., et al. (2010).  Prevalence and clinical outcomes of incidentally diagnosed hypertrophic cardiomyopathy.. Am J Cardiol. 105(10), 1445-50.
Pagourelias, E. D., Efthimiadis G. K., Parcharidou D. G., Pliakos C., & Styliadis I. H. (2010).  Prognostic implications of the Doppler restrictive filling pattern in hypertrophic cardiomyopathy.. Am J Cardiol. 105(9), 1358.
Pagourelias, E. D., Efthimiadis G. K., Parcharidou D. G., Gossios T. D., Kamperidis V., Karoulas T., et al. (2011).  Prognostic value of right ventricular diastolic function indices in hypertrophic cardiomyopathy.. Eur J Echocardiogr. 12(11), 809-17.
Pagourelias, E. D., Gossios T. D., Tziomalos K., Karagiannis A., Geleris P., & Athyros V. G. (2011).  Residual cardiac risk reduction beyond lipid lowering.. Hellenic J Cardiol. 52(3), 197-203.
Athyros, V. G., Tziomalos K., Gossios T. D., Griva T., Anagnostis P., Kargiotis K., et al. (2010).  Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis.. Lancet. 376(9756), 1916-22.
Karagiannis, A., Tziomalos K., Mikhailidis D. P., Semertzidis P., Kountana E., Kakafika A. I., et al. (2010).  Seasonal variation in the occurrence of stroke in Northern Greece: a 10 year study in 8204 patients.. Neurol Res. 32(3), 326-31.
Karagiannis, A., Tziomalos K., Papageorgiou A., Kakafika A. I., Pagourelias E. D., Anagnostis P., et al. (2008).  Spironolactone versus eplerenone for the treatment of idiopathic hyperaldosteronism.. Expert Opin Pharmacother. 9(4), 509-15.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.